PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY APPLICATION • Segmentation by application • Comparison by application • Pharmaceutical – Market size and forecast 2017-2022 • Healthcare – Market size and forecast 2017-2022 • Others – Market size and forecast 2017-2022 • Market opportunity by application PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas – Market size and forecast 2017-2022 • EMEA – Market size and forecast 2017-2022 • APAC – Market size and forecast 2017-2022 • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Bioproduction driving demand for microbial culture • Increasing importance of promotional activities • Outbreak of infectious diseases • Rising demand for cosmetics PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Bio-Rad Laboratories • Danaher • Merck KGaA • QIAGEN • Thermo Fisher Scientific PART 15: APPENDIX • List of abbreviations Exhibit 01: Parent market Exhibit 02: Global microbial testing market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global microbiology reagents market– Market size and forecast 2017-2022 ($ mn) Exhibit 09: Global microbiology reagents market – Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 Exhibit 18: Application – Market share 2017-2022 (%) Exhibit 19: Comparison by application Exhibit 20: Pharmaceutical – Market size and forecast 2017-2022 ($ mn) Exhibit 21: Pharmaceutical – Year-over-year growth 2018-2022 (%) Exhibit 22: Healthcare – Market size and forecast 2017-2022 ($ mn) Exhibit 23: Healthcare – Year-over-year growth 2018-2022 (%) Exhibit 24: Others – Market size and forecast 2017-2022 ($ mn) Exhibit 25: Others – Year-over-year growth 2018-2022 (%) Exhibit 26: Market opportunity by application Exhibit 27: Customer landscape Exhibit 28: Global microbiology reagents market – Market share by geography 2017-2022 (%) Exhibit 29: Regional comparison Exhibit 30: Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 31: Americas – Year-over-year growth 2018-2022 (%) Exhibit 32: Top 3 countries in Americas Exhibit 33: EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 34: EMEA – Year-over-year growth 2018-2022 (%) Exhibit 35: Top 3 countries in EMEA Exhibit 36: APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 37: APAC – Year-over-year growth 2018-2022 (%) Exhibit 38: Top 3 countries in APAC Exhibit 39: Market opportunity Exhibit 40: Some examples of infectious diseases caused by pathogenic microorganisms Exhibit 41: Vendor landscape Exhibit 42: Landscape disruption Exhibit 43: Vendors covered Exhibit 44: Vendor classification Exhibit 45: Market positioning of vendors Exhibit 46: Bio-Rad Laboratories – Overview Exhibit 47: Bio-Rad Laboratories – Business segments Exhibit 48: Bio-Rad Laboratories – Organizational developments Exhibit 49: Bio-Rad Laboratories – Geographic focus Exhibit 50: Bio-Rad Laboratories – Segment focus Exhibit 51: Bio-Rad Laboratories – Key offerings Exhibit 52: Danaher – Overview Exhibit 53: Danaher – Business segments Exhibit 54: Danaher – Organizational developments Exhibit 55: Danaher – Geographic focus Exhibit 56: Danaher – Segment focus Exhibit 57: Danaher – Key offerings Exhibit 58: Merck KGaA – Overview Exhibit 59: Merck KGaA – Business segments Exhibit 60: Merck KGaA – Organizational developments Exhibit 61: Merck KGaA – Geographic focus Exhibit 62: Merck KGaA – Segment focus Exhibit 63: Merck KGaA – Key offerings Exhibit 64: QIAGEN – Overview Exhibit 65: QIAGEN – Product segments Exhibit 66: QIAGEN – Organizational developments Exhibit 67: QIAGEN – Geographic focus Exhibit 68: QIAGEN – Product segment focus Exhibit 69: QIAGEN – Key offerings Exhibit 70: Thermo Fisher Scientific – Overview Exhibit 71: Thermo Fisher Scientific – Business segments Exhibit 72: Thermo Fisher Scientific – Organizational developments Exhibit 73: Thermo Fisher Scientific – Geographic focus Exhibit 74: Thermo Fisher Scientific – Segment focus Exhibit 75: Thermo Fisher Scientific – Key offerings

Bio-Rad Laboratories, Danaher, Merck KGaA, QIAGEN, Thermo Fisher Scientific